A number of other hedge funds and other institutional investors have also modified their holdings of the stock. GKV Capital Management Co. Inc. bought a new stake in Pfizer during the first quarter worth $27,000. North Capital Inc. acquired a new position in shares of Pfizer during the 1st quarter worth about $28,000. Bayforest Capital Ltd acquired a new position in shares of Pfizer during the 1st quarter worth about $28,000. Horizon Financial Services LLC acquired a new position in shares of Pfizer during the 1st quarter worth about $35,000. Finally, WPG Advisers LLC acquired a new position in shares of Pfizer during the 1st quarter worth about $35,000. Institutional investors and hedge funds own 68.36% of the company's stock.